These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16938650)

  • 41. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    Sheneef A; Esmat MM; Mohammad AN; Mahmoud AA; Moghazy HM; Noureldin AK
    J Interferon Cytokine Res; 2017 Apr; 37(4):175-180. PubMed ID: 28387594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis.
    Vallinoto AC; Graça ES; Araújo MS; Azevedo VN; Cayres-Vallinoto I; Machado LF; Ishak MO; Ishak R
    Hum Immunol; 2010 Jul; 71(7):692-6. PubMed ID: 20353805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
    Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
    Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infection.
    Ryan EJ; Dring M; Ryan CM; McNulty C; Stevenson NJ; Lawless MW; Crowe J; Nolan N; Hegarty JE; O'Farrelly C
    Hum Immunol; 2010 Aug; 71(8):829-32. PubMed ID: 20470843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus load.
    Arase Y; Suzuki F; Sezaki H; Kawamura Y; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Yatsuji H; Hirakawa M; Kobayashi M; Ikeda K; Kumada H
    Intervirology; 2008; 51(4):265-9. PubMed ID: 18841028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
    Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
    Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
    J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
    Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F
    J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression.
    Bahgat NA; Kamal MM; Abdelaziz AO; Mohye MA; Shousha HI; ahmed MM; Elbaz TM; Nabil MM
    Asian Pac J Cancer Prev; 2015; 16(12):5025-30. PubMed ID: 26163635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.
    Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P
    Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma and interleukin-4 single nucleotide gene polymorphisms in Paracoccidioidomycosis.
    Bozzi A; Reis BS; Pereira PP; Pedroso EP; Goes AM
    Cytokine; 2009 Dec; 48(3):212-7. PubMed ID: 19682920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single nucleotide polymorphisms in the interferon-gamma and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus.
    Abbott WG; Rigopoulou E; Haigh P; Cooksley H; Mullerova I; Novelli M; Winstanley A; Williams R; Naoumov NV
    Liver Int; 2004 Apr; 24(2):90-7. PubMed ID: 15078471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-γ with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C.
    Korachi M; Ceran N; Adaleti R; Nigdelioglu A; Sökmen M
    Int J Infect Dis; 2013 Jan; 17(1):e44-9. PubMed ID: 23040881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
    Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H
    J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic steatosis in Iranian patients with chronic hepatitis C.
    Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
    Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
    Bouzgarrou N; Hassen E; Schvoerer E; Stoll-Keller F; Bahri O; Gabbouj S; Cheikh I; Maamouri N; Mammi N; Saffar H; Trabelsi A; Triki H; Chouchane L
    J Med Virol; 2008 Apr; 80(4):607-14. PubMed ID: 18297714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.